The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease: An 8-Year Follow-up in the Copenhagen Male Study
Abstract
Abstract High triglyceride (TG) and low HDL cholesterol (HDL-C) is the characteristic dyslipidemia seen in insulin-resistant subjects. We examined the role of this dyslipidemia as a risk factor of ischemic heart disease (IHD) compared with that of high LDL cholesterol (LDL-C) in the Copenhagen Male Study. In total 2910 white men, aged 53 to 74 years, free of cardiovascular disease at baseline, were subdivided into four groups on the basis of fasting concentrations of serum TG, HDL-C, and LDL-C. “High TG–low HDL-C” was defined as belonging to both the highest third of TG and the lowest third of HDL-C; this group encompassed one fifth of the population. “High LDL-C” was defined as belonging to the highest fifth of LDL-C. A control group was defined as not belonging to either of these two groups. “Combined dyslipidemia” was defined as belonging to both dyslipidemic groups. Age-adjusted incidence of IHD during 8 years of follow-up was 11.4% in high TG–low HDL-C, 8.2% in high LDL-C, 6.6% in the control group, and 17.5% in combined dyslipidemia. Compared with the control group, relative risks of IHD (95% confidence interval), adjusted for potentially confounding factors or covariates (age, body mass index, alcohol consumption, physical activity, non–insulin-dependent diabetes, hypertension, smoking, and social class), were 1.5 (1.0-2.1), P <.05; 1.3 (0.9-2.0), P =.16; and 2.4 (1.5-4.0), P <.01, in the three dyslipidemic groups, respectively. In conclusion, the present results showed that high TG–low HDL-C, the characteristic dyslipidemia seen in insulin-resistant subjects, was at least as powerful a predictor of IHD as isolated high LDL-C. The results suggest that efforts to prevent IHD should include intervention against high TG–low HDL-C, and not just against hypercholesterolemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
BURSTEIN, M., SCHOLNICK, H. R., & MORFIN, R. (1970) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42943-8 · Cited by 2,491
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,246
Cholesterol determination in high-density lipoproteins separated by three different methods.
Lopes-Virella, M. F., Stone, P., Ellis, S., & Colwell, J. A. (1977) · Clinical Chemistry · doi:10.1093/clinchem/23.5.882 · Cited by 1,841
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Hamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
Hulley, S. B., Rosenman, R. H., Bawol, R. D., & Brand, R. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006193022503 · Cited by 702
Plasma triglyceride and coronary heart disease
Austin, M. A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.2 · Cited by 697
Reaven, G. M., Chen, Y. D., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 690
Self-citationCholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios
Kinosian, B., Glick, H., & Garland, G. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-9-199411010-00002 · Cited by 519
Postprandial lipoproteins and progression of coronary atherosclerosis
Karpe, F., Steiner, G., Uffelman, K., Olivecrona, T., & Hamsten, A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90085-x · Cited by 483
Plasma Triglyceride Level and Mortality from Coronary Heart Disease
Criqui, M. H., Heiss, G., Cohn, R., Cowan, L. D., Suchindran, C. M., Bangdiwala, S., Kritchevsky, S., Jacobs, D. R., O'Grady, H. K., & Davis, C. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281702 · Cited by 418
Epidemiology of triglycerides: A view from Framingham
Castelli, W. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91083-g · Cited by 346
A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS
Rose, G. A., Holland, W. W., & Crowley, E. A. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92408-0 · Cited by 330
LAWS, A., & REAVEN, G. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00494.x · Cited by 291
Laakso, M., Sarlund, H., & Mykkänen, L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.223 · Cited by 286
Tobey, T. A., Greenfield, M., Kraemer, F., & Reaven, G. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90167-0 · Cited by 243
Reaven, G. M. (1994) · PubMed · Cited by 241
Mehta, J., Mehta, P., Lawson, D., & Saldeen, T. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80373-x · Cited by 239
Bainton, D., Miller, N. E., Bolton, C. H., Yarnell, J. W. G., Sweetnam, P. M., Baker, I. A., Lewis, B., & Elwood, P. C. (1992) · Heart · doi:10.1136/hrt.68.7.60 · Cited by 210
Management of Primary Hyperlipidemia
Havel, R. J., & Rapaport, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322207 · Cited by 188
Abbott, W. G. H., Lillioja, S., Young, A. A., Zawadzki, J. K., Yki-Järvinen, H., Christin, L., & Howard, B. V. (1987) · Diabetes · doi:10.2337/diab.36.8.897 · Cited by 166
Relationship between lipoprotein levels and in vivo insulin action in normal young white men
Garg, A., Helderman, J. H., Koffler, M., Ayuso, R. M. A., Rosenstock, J., & Raskin, P. (1988) · Metabolism · doi:10.1016/0026-0495(88)90157-6 · Cited by 142
Physical fitness and coronary heart disease in male residents in Copenhagen aged 40-59.
Gyntelberg, F. (1973) · PubMed · Cited by 121
Self-citationInsulin, intact and split proinsulin, and coronary artery disease in young men.
Båvenholm, P., Proudler, A., Tornvall, P., Godsland, I., Landou, C., de Faire, U., & Hamsten, A. (1995) · Circulation · doi:10.1161/01.cir.92.6.1422 · Cited by 109
Sheu, W. H., Shieh, S.-M., Fuh, M. M.-T., Shen, D. D., Jeng, C. Y., Chen, Y. I., & Reaven, G. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.3.367 · Cited by 88
Coagulation Factor VII Mass and Activity in Young Men With Myocardial Infarction at a Young Age
Moor, E., Silveira, A. M. V., Hooft, F. M. V., Suontaka, A. M., Eriksson, P. O., Blombäck, M., & Hamsten, A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.655 · Cited by 73
Serum Validated Tobacco Use and Social Inequalities in Risk of Ischaemic Heart Disease
Suadicani, P., Hein, H. O., & Gyntelberg, F. (1994) · International Journal of Epidemiology · doi:10.1093/ije/23.2.293 · Cited by 71
Self-citationOne- and two-years incidence of myocardial infarction in copenhagen males aged 40-59.
Gyntelberg, F. (1975) · PubMed · Cited by 40
Self-citation
Cited by
Dairy Consumption, Obesity, and the Insulin Resistance Syndrome in Young Adults: The CARDIA Study
Pereira, M. A., Jacobs, Jr., Van Horn, L., Slattery, M. L., Kartashov, A. I., & Ludwig, D. S. (2002) · JAMA · doi:10.1001/jama.287.16.2081 · Cited by 1,102
HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA)
HORROCKS, L. A., & YEO, Y. K. (1999) · Pharmacological Research · doi:10.1006/phrs.1999.0495 · Cited by 1,031
Lipids and Lipoproteins in Patients With Type 2 Diabetes
Krauss, R. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1496 · Cited by 756
Fatty acid profiles of 80 vegetable oils with regard to their nutritional potential
Dubois, V., Breton, S., Linder, M., Fanni, J., & Parmentier, M. (2007) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200700040 · Cited by 659
McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658
Metadata
- Authors
- Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-06
- Volume
- 17
- Issue
- 6
- Pages
- 1114-1120
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2130782066
- Cited by
- 274
- References
- 30
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.